These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 9375831
21. Substitution of chromosome 1 ameliorates L-NAME hypertension and renal disease in the fawn-hooded hypertensive rat. Mattson DL, Kunert MP, Roman RJ, Jacob HJ, Cowley AW. Am J Physiol Renal Physiol; 2005 May; 288(5):F1015-22. PubMed ID: 15644486 [Abstract] [Full Text] [Related]
22. Addition of AT1 blocker fails to overcome resistance to ACE inhibition in adriamycin nephrosis. Bos H, Henning RH, De Boer E, Tiebosch AT, De Jong PE, De Zeeuw D, Navis G. Kidney Int; 2002 Feb; 61(2):473-80. PubMed ID: 11849387 [Abstract] [Full Text] [Related]
23. Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor. Keilani T, Schlueter WA, Levin ML, Batlle DC. Ann Intern Med; 1993 Feb 15; 118(4):246-54. PubMed ID: 8420442 [Abstract] [Full Text] [Related]
24. Reduction of mean arterial pressure and proteinuria by the effect of ACEIs (Lisinopril) in Kurdish hypertensive patients in Hawler City. Muslih AI. Glob J Health Sci; 2012 Jun 30; 4(5):14-9. PubMed ID: 22980373 [Abstract] [Full Text] [Related]
25. Chromosomal mapping of the genetic basis of hypertension and renal disease in FHH rats. Mattson DL, Dwinell MR, Greene AS, Kwitek AE, Roman RJ, Cowley AW, Jacob HJ. Am J Physiol Renal Physiol; 2007 Dec 30; 293(6):F1905-14. PubMed ID: 17898042 [Abstract] [Full Text] [Related]
26. Effect of angiotensin II antagonism on the regression of kidney disease in the rat. Remuzzi A, Gagliardini E, Donadoni C, Fassi A, Sangalli F, Lepre MS, Remuzzi G, Benigni A. Kidney Int; 2002 Sep 30; 62(3):885-94. PubMed ID: 12164870 [Abstract] [Full Text] [Related]
27. Renal accumulation of pentosidine in non-diabetic proteinuria-induced renal damage in rats. Waanders F, Greven WL, Baynes JW, Thorpe SR, Kramer AB, Nagai R, Sakata N, van Goor H, Navis G. Nephrol Dial Transplant; 2005 Oct 30; 20(10):2060-70. PubMed ID: 15956058 [Abstract] [Full Text] [Related]
28. Do severe systemic sequelae of proteinuria modulate the antiproteinuric response to chronic ACE inhibition? Bos H, Henning RH, De Jong PE, De Zeeuw D, Navis G. Nephrol Dial Transplant; 2002 May 30; 17(5):793-7. PubMed ID: 11981065 [Abstract] [Full Text] [Related]
29. Comparative antihypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats. Wienen W, Richard S, Champeroux P, Audeval-Gerard C. J Renin Angiotensin Aldosterone Syst; 2001 Mar 30; 2(1):31-6. PubMed ID: 11881063 [Abstract] [Full Text] [Related]
30. Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis. Wapstra FH, Van Goor H, Navis G, De Jong PE, De Zeeuw D. Clin Sci (Lond); 1996 May 30; 90(5):393-401. PubMed ID: 8665777 [Abstract] [Full Text] [Related]
31. Dissociation between antiproteinuric and antihypertensive effect of angiotensin converting enzyme inhibitors in rats. Remuzzi A, Imberti O, Puntorieri S, Malanchini B, Macconi D, Magrini L, Bertani T, Remuzzi G. Am J Physiol; 1994 Dec 30; 267(6 Pt 2):F1034-44. PubMed ID: 7528985 [Abstract] [Full Text] [Related]
32. Effect of proteinuria reduction on prevention of focal glomerulosclerosis by angiotensin-converting enzyme inhibition is modifiable. de Boer E, Navis G, Wapstra FH, de Jong PE, de Zeeuw D. Kidney Int Suppl; 1999 Jul 30; 71():S42-6. PubMed ID: 10412735 [Abstract] [Full Text] [Related]
33. Blood pressure and the susceptibility to renal damage after unilateral nephrectomy and L-NAME-induced hypertension in rats. van Dokkum RP, Jacob HJ, Provoost AP. Nephrol Dial Transplant; 2000 Sep 30; 15(9):1337-43. PubMed ID: 10978388 [Abstract] [Full Text] [Related]
34. Effects of perindopril on serum lipids in hypertensive patients with hyperlipidemia. Middeke M, Krone W. J Cardiovasc Pharmacol; 1994 Apr 30; 23(4):629-31. PubMed ID: 7516014 [Abstract] [Full Text] [Related]
35. Tubuloglomerular feedback and prolonged ACE-inhibitor treatment in the hypertensive fawn-hooded rat. Verseput GH, Braam B, Provoost AP, Koomans HA. Nephrol Dial Transplant; 1998 Apr 30; 13(4):893-9. PubMed ID: 9568846 [Abstract] [Full Text] [Related]
36. Effects of angiotensin-converting enzyme inhibitors on glucose and lipid metabolism in essential hypertension. Oksa A, Gajdos M, Fedelesová V, Spustová V, Dzúrik R. J Cardiovasc Pharmacol; 1994 Jan 30; 23(1):79-86. PubMed ID: 7511740 [Abstract] [Full Text] [Related]
37. Renal endothelial function is associated with the anti-proteinuric effect of ACE inhibition in 5/6 nephrectomized rats. Vettoretti S, Vavrinec P, Ochodnicky P, Deelman LE, De Zeeuw D, Henning RH, Buikema H. Am J Physiol Renal Physiol; 2016 May 01; 310(10):F1047-53. PubMed ID: 26911850 [Abstract] [Full Text] [Related]
38. Effects of chronic treatment with lisinopril on cardiovascular complications in streptozotocin diabetic and DOCA hypertensive rats. Sevak AR, Goyal RK. Pharmacol Res; 1996 May 01; 34(5-6):201-9. PubMed ID: 9076844 [Abstract] [Full Text] [Related]
39. Renoprotection by nitric oxide donor and lisinopril in the remnant kidney model. Benigni A, Zoja C, Noris M, Corna D, Benedetti G, Bruzzi I, Todeschini M, Remuzzi G. Am J Kidney Dis; 1999 Apr 01; 33(4):746-53. PubMed ID: 10196019 [Abstract] [Full Text] [Related]
40. AT-1 receptor blockade prevents proteinuria, renal failure, hyperlipidemia, and glomerulosclerosis in the Imai rat. Rodríguez-Iturbe B, Sato T, Quiroz Y, Vaziri ND. Kidney Int; 2004 Aug 01; 66(2):668-75. PubMed ID: 15253721 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]